Biodesix, Inc.
BDSX
$0.8622
$0.01221.44%
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 1.26% | 20.97% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 1.26% | 20.97% | |||
| Cost of Revenue | 7.79% | 22.11% | |||
| Gross Profit | -0.54% | 20.66% | |||
| SG&A Expenses | 1.81% | -4.36% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 2.48% | 1.26% | |||
| Operating Income | -5.15% | 25.41% | |||
| Income Before Tax | 5.09% | 20.61% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 5.09% | 20.61% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 5.09% | 20.61% | |||
| EBIT | -5.15% | 25.41% | |||
| EBITDA | -5.05% | 29.11% | |||
| EPS Basic | 17.53% | 39.33% | |||
| Normalized Basic EPS | 15.12% | 40.76% | |||
| EPS Diluted | 17.53% | 39.33% | |||
| Normalized Diluted EPS | 15.12% | 40.76% | |||
| Average Basic Shares Outstanding | 15.04% | 30.88% | |||
| Average Diluted Shares Outstanding | 15.04% | 30.88% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
